443 related articles for article (PubMed ID: 30088174)
1. PARK14 (D331Y) PLA2G6 Causes Early-Onset Degeneration of Substantia Nigra Dopaminergic Neurons by Inducing Mitochondrial Dysfunction, ER Stress, Mitophagy Impairment and Transcriptional Dysregulation in a Knockin Mouse Model.
Chiu CC; Lu CS; Weng YH; Chen YL; Huang YZ; Chen RS; Cheng YC; Huang YC; Liu YC; Lai SC; Lin KJ; Lin YW; Chen YJ; Chen CL; Yeh TH; Wang HL
Mol Neurobiol; 2019 Jun; 56(6):3835-3853. PubMed ID: 30088174
[TBL] [Abstract][Full Text] [Related]
2. PLA2G6 mutations cause motor dysfunction phenotypes of young-onset dystonia-parkinsonism type 14 and can be relieved by DHA treatment in animal models.
Yeh TH; Liu HF; Chiu CC; Cheng ML; Huang GJ; Huang YC; Liu YC; Huang YZ; Lu CS; Chen YC; Chen HY; Cheng YC
Exp Neurol; 2021 Dec; 346():113863. PubMed ID: 34520727
[TBL] [Abstract][Full Text] [Related]
3. Azoramide protects iPSC-derived dopaminergic neurons with PLA2G6 D331Y mutation through restoring ER function and CREB signaling.
Ke M; Chong CM; Zeng H; Huang M; Huang Z; Zhang K; Cen X; Lu JH; Yao X; Qin D; Su H
Cell Death Dis; 2020 Feb; 11(2):130. PubMed ID: 32071291
[TBL] [Abstract][Full Text] [Related]
4. PARK14 PLA2G6 mutants are defective in preventing rotenone-induced mitochondrial dysfunction, ROS generation and activation of mitochondrial apoptotic pathway.
Chiu CC; Yeh TH; Lu CS; Huang YC; Cheng YC; Huang YZ; Weng YH; Liu YC; Lai SC; Chen YL; Chen YJ; Chen CL; Chen HY; Lin YW; Wang HL
Oncotarget; 2017 Oct; 8(45):79046-79060. PubMed ID: 29108286
[TBL] [Abstract][Full Text] [Related]
5. PLA2G6 accumulates in Lewy bodies in PARK14 and idiopathic Parkinson's disease.
Miki Y; Tanji K; Mori F; Kakita A; Takahashi H; Wakabayashi K
Neurosci Lett; 2017 Apr; 645():40-45. PubMed ID: 28213071
[TBL] [Abstract][Full Text] [Related]
6. Parkinson's disease-associated
Mori A; Hatano T; Inoshita T; Shiba-Fukushima K; Koinuma T; Meng H; Kubo SI; Spratt S; Cui C; Yamashita C; Miki Y; Yamamoto K; Hirabayashi T; Murakami M; Takahashi Y; Shindou H; Nonaka T; Hasegawa M; Okuzumi A; Imai Y; Hattori N
Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20689-20699. PubMed ID: 31548400
[TBL] [Abstract][Full Text] [Related]
7. Genotype-phenotype correlations of adult-onset PLA2G6-associated Neurodegeneration: case series and literature review.
Chu YT; Lin HY; Chen PL; Lin CH
BMC Neurol; 2020 Mar; 20(1):101. PubMed ID: 32183746
[TBL] [Abstract][Full Text] [Related]
8. Pla2g6 Deficiency in Zebrafish Leads to Dopaminergic Cell Death, Axonal Degeneration, Increased β-Synuclein Expression, and Defects in Brain Functions and Pathways.
Sánchez E; Azcona LJ; Paisán-Ruiz C
Mol Neurobiol; 2018 Aug; 55(8):6734-6754. PubMed ID: 29344929
[TBL] [Abstract][Full Text] [Related]
9. Generation of induced pluripotent stem cells from a young-onset Parkinson's disease patient carrying the compound heterozygous PLA2G6 p.D331Y/p.M358IfsX mutations.
Chiu CC; Wang HL; Weng YH; Chen RS; Chen CM; Yeh TH; Lu CS; Chen YJ; Liu YC; Huang YZ; Chang KH
Stem Cell Res; 2019 Oct; 40():101552. PubMed ID: 31493761
[TBL] [Abstract][Full Text] [Related]
10. High expression of α-synuclein in damaged mitochondria with PLA2G6 dysfunction.
Sumi-Akamaru H; Beck G; Shinzawa K; Kato S; Riku Y; Yoshida M; Fujimura H; Tsujimoto Y; Sakoda S; Mochizuki H
Acta Neuropathol Commun; 2016 Mar; 4():27. PubMed ID: 27030050
[TBL] [Abstract][Full Text] [Related]
11. Parkin deficiency exacerbate ethanol-induced dopaminergic neurodegeneration by P38 pathway dependent inhibition of autophagy and mitochondrial function.
Hwang CJ; Kim YE; Son DJ; Park MH; Choi DY; Park PH; Hellström M; Han SB; Oh KW; Park EK; Hong JT
Redox Biol; 2017 Apr; 11():456-468. PubMed ID: 28086194
[TBL] [Abstract][Full Text] [Related]
12. Impairment of PARK14-dependent Ca(2+) signalling is a novel determinant of Parkinson's disease.
Zhou Q; Yen A; Rymarczyk G; Asai H; Trengrove C; Aziz N; Kirber MT; Mostoslavsky G; Ikezu T; Wolozin B; Bolotina VM
Nat Commun; 2016 Jan; 7():10332. PubMed ID: 26755131
[TBL] [Abstract][Full Text] [Related]
13. REST Protects Dopaminergic Neurons from Mitochondrial and α-Synuclein Oligomer Pathology in an Alpha Synuclein Overexpressing BAC-Transgenic Mouse Model.
Ryan BJ; Bengoa-Vergniory N; Williamson M; Kirkiz E; Roberts R; Corda G; Sloan M; Saqlain S; Cherubini M; Poppinga J; Bogtofte H; Cioroch M; Hester S; Wade-Martins R
J Neurosci; 2021 Apr; 41(16):3731-3746. PubMed ID: 33563726
[TBL] [Abstract][Full Text] [Related]
14. CNTNAP4 deficiency in dopaminergic neurons initiates parkinsonian phenotypes.
Zhang W; Zhou M; Lu W; Gong J; Gao F; Li Y; Xu X; Lin Y; Zhang X; Ding L; Zhang Z; Li G; Chen X; Sun X; Zhu X; Xu P; Zhang Y
Theranostics; 2020; 10(7):3000-3021. PubMed ID: 32194851
[No Abstract] [Full Text] [Related]
15. Minocycline inhibition of microglial rescues nigrostriatal dopaminergic neurodegeneration caused by mutant alpha-synuclein overexpression.
Wang Y; Wang Q; Yu R; Zhang Q; Zhang Z; Li H; Ren C; Yang R; Niu H
Aging (Albany NY); 2020 Jul; 12(14):14232-14243. PubMed ID: 32706757
[TBL] [Abstract][Full Text] [Related]
16. Reprogramming of a human induced pluripotent stem cell (iPSC) line (IBMSi012-A) from an early-onset Parkinson's disease patient harboring a homozygous p.D331Y mutation in the PLA2G6 gene.
Cheng YC; Lin HI; Syu SH; Lu HE; Huang CY; Lin CH; Hsieh PCH
Stem Cell Res; 2019 May; 37():101432. PubMed ID: 30978640
[TBL] [Abstract][Full Text] [Related]
17. (D620N) VPS35 causes the impairment of Wnt/β-catenin signaling cascade and mitochondrial dysfunction in a PARK17 knockin mouse model.
Chiu CC; Weng YH; Huang YZ; Chen RS; Liu YC; Yeh TH; Lu CS; Lin YW; Chen YJ; Hsu CC; Chiu CH; Wang YT; Chen WS; Liu SY; Wang HL
Cell Death Dis; 2020 Nov; 11(11):1018. PubMed ID: 33257649
[TBL] [Abstract][Full Text] [Related]
18. (R1441C) LRRK2 induces the degeneration of SN dopaminergic neurons and alters the expression of genes regulating neuronal survival in a transgenic mouse model.
Weng YH; Chen CY; Lin KJ; Chen YL; Yeh TH; Hsiao IT; Chen IJ; Lu CS; Wang HL
Exp Neurol; 2016 Jan; 275 Pt 1():104-15. PubMed ID: 26363496
[TBL] [Abstract][Full Text] [Related]
19. PLA2G6 gene mutation in autosomal recessive early-onset parkinsonism in a Chinese cohort.
Shi CH; Tang BS; Wang L; Lv ZY; Wang J; Luo LZ; Shen L; Jiang H; Yan XX; Pan Q; Xia K; Guo JF
Neurology; 2011 Jul; 77(1):75-81. PubMed ID: 21700586
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
